Collagenex Pharmaceuticals Aktie [WKN: 901491 / ISIN: US19419B1008]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Einfügen in
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Depot
Times + Sales	Analysechart (Java)	Analysen	Dividende/HV	Profil	Optionsscheine	Watchlist
Börsenplätze		Research Statis.		Insidertrades	Knock-outs	myfinanzen
Orderbuch	Realtime Stuttgart	RSS Feed		im Forum	Fonds
Historisch	Realtime Push			IR-Daten	Anleihen

Nachrichten zu Collagenex Pharmaceuticals Inc.

19.03.08	CollaGenex Pharmaceuticals Announces Expiration of the Hart-Scott-Rodino Waiting Period for Merger with Galderma Pharma S.A.
12.03.08	CollaGenex Pharmaceuticals Reports Financial Results for the Fourth Quarter and Full Year 2007
05.03.08	CollaGenex Pharmaceuticals to Host Fourth Quarter and Full Year 2007 Financial Results Conference Call on March 12th
26.02.08	CollaGenex Pharmaceuticals Signs Merger Agreement with Galderma Pharma S.A.
14.02.08	CollaGenex Pharmaceuticals to Present at Roth Capital Partners' 20th Annual OC Growth Stock Conference on February 20th
23.01.08	CollaGenex Pharmaceuticals to Present at the 2008 Wachovia Healthcare Conference on January 30th
17.01.08	CollaGenex Pharmaceuticals Announces Results of Phase 4 Clinical Study Showing Oracea Equally Effective as 100 mg Doxycycline in Treatment of Rosacea
14.01.08	CollaGenex Pharmaceuticals Initiates Phase 2 Dose-Finding Study of Becocalcidiol for the Treatment of Psoriasis

03.03.08	CollaGenex Pharmaceuticals Downgrade	ROTH Capital Partners, LLC
28.02.08	CollaGenex Pharmaceuticals Downgrade	Wachovia Securities, LLC
27.02.08	CollaGenex Pharmaceuticals Downgrade	Rodman & Renshaw, LLC
07.11.07	CollaGenex Pharmaceuticals Downgrade	Jefferies & Company Inc.
27.09.07	CollaGenex Pharmaceuticals neues Kursziel	ROTH Capital Partners, LLC